PRPO Precipio Inc: Year-over-year earnings per share growth for the last twelve months

Graphic logo of Precipio, Inc. (PRPO)

Precipio, Inc. relies on a stable staff of leading pathologists and cytogeneticists, despite a local shortage of laboratory technicians. The quarterly earnings per share growth rate helps assess the business fundamentals, where -365.90 represents the current metric. Automated oncology analysis centers in the US ensure efficiency, although disrupted supply chains and sanctions limit access to international databases.

PRPO: Precipio Earnings per share growth in annualized terms for the last twelve months 07/04/2022 - 11/11/2026

Summary analytical data breakdowns for Precipio Inc (PRPO)

- share price and expert price forecast:
Stock Price Precipio|PRPO - Analyst Consensus Forecast
- company stock capitalization data:
Market Value Precipio, Inc|PRPO - Total Company Value
- book capitalization data:
Accounting Value per Share Precipio|PRPO - Total Stockholders' Equity|Market Value to Book Value Ratio precipiodx.com|PRPO - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Capital Precipio, Inc.|PRPO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Precipio, Inc.|PRPO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Precipio, Inc|PRPO - Long-Term Liabilities|Company Short-Term Debt Precipio|Quick Ratio precipiodx.com
- earnings and valuation multiples information:
PRPO - Company Net Income|Projected Future Earnings Precipio, Inc.|PRPO - Price to Earnings Ratio|Forward P/E Multiple Precipio, Inc|PRPO - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precipio, Inc|PRPO - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Precipio|PRPO - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months precipiodx.com|PRPO - Earnings per share growth rate in current year|Expected earnings per share growth for next year Precipio, Inc.
Analysis of all company metrics:Precipio, Inc.
Flagship merchandise of Precipio, Inc.

Precipio, Inc. (PRPO) maintains high margins through its pricing power in oncology diagnostics, driven by the unique ICE-COLD PCR technology and inelastic demand for critical tests. The quarterly EPS trend digitizes net income per share dynamics, enabling investors to assess real business efficiency and promptly identify asset overvaluation relative to its fundamental growth rates.

Competing companies

CAI: Quarterly EPS earnings growth|Guardant Health Inc (GH) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Veracyte Corp|Year-over-year earnings per share growth for the last twelve months CELC|Year-over-year net earnings per share growth for the last 12 months GRAL (GRAIL, Inc.)|MYGN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Castle Biosciences, Inc. CSTL|Year-over-year net earnings per share change for the last twelve months Burning Rock Biotech Limited (BNR)|VolitionRx Ltd - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Biodesix Corporation BDSX|check-cap.com (CHEK) - Year-over-year earnings per share growth for the last twelve months|MYNZ - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months OncoCyte